Joo Hang Kim
CHA University Bundang Medical Center · 174 works · 7,440 citations · h-index 30
Top works
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
- Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of Gefitinib
- Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy
- Distinct clinical features and outcomes in never‐smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
- Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
- Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification
- Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
- Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
- Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma
- Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
- Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis
- Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression
- Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression
- Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
- Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
- Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
- P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer
- Efficacy and safety of dovitinib in pretreated patients with advanced squamous non‐small cell lung cancer with FGFR1 amplification: A single‐arm, phase 2 study
- Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors